Abstract β-Catenin is essential for muscle development because it regulates both cadherin-mediated cell-cell adhesion and canonical Wingless and Int1 (Wnt) signaling. The phosphorylation of β-catenin by glycogen synthase kinase-3β (GSK-3β) at serine31/37/threonine41 regulates its stability and its role in canonical Wnt signaling. In this study, we have investigated whether the N-terminal phosphorylation of β-catenin is regulated by M-cadherin, and whether this regulation mediates the role of M-cadherin in myogenic differentiation. Our data show that the knockdown of Mcadherin expression by RNA interference (RNAi) in C2C12 myoblasts significantly increases the phosphorylation of β-catenin at Ser33/37/Thr41 and decreases the protein abundance of ser37/thr41-unphosphorylated active β-catenin. Furthermore, M-cadherin RNAi promotes TCF/LEF transcription activity but also blunts the initiation of the myogenic progress by Wnt pathway activator lithium chloride or Wnt-3a treatment. Knockdown of β-catenin expression by RNAi decreases myogenic induction in myoblasts. Forced expression of a phosphorylation-resistant β-catenin plasmid (S33Y-β-catenin) fails to enhance myogenic differentiation, but it partially rescues C2C12 cells from M-cadherin RNAiinduced apoptosis. These data show, for the first time, that M-cadherin-mediated signaling attenuates β-catenin phosphorylation at Ser31/37/Thr41 by GSK-3β, and that this regulation has a positive effect on myogenic differentiation induced by canonical Wnt signaling.
Introduction
Muscle progenitor stem cells (i.e., satellite cells) are normally quiescent in adult muscles under basal physiological conditions. However, once they are activated in response to injury or exercise, they recapitulate development by entering the cell cycle, proliferate, differentiate, and finally fuse into myotubes (Zammit et al. 2006) .
Canonical Wingless and Int1 (Wnt) signaling clearly plays an important regulatory role in many cellular events such as proliferation, differentiation, and morphogenesis in many cell types, including skeletal muscle cells (Zhang et al. 2012) . β-Catenin is a member of the armadillo family of proteins, it is a key transcription cofactor in the Wnt signaling pathway, it can modify the activity of the T cell factor/lymphoid enhancer factor (TCF/LEF) family of DNA-binding proteins Ishitani et al. 2003) , and it is a central structural adaptor protein linking cadherins to the actin cytoskeleton in intercellular adherens junctions (Nelson and Nusse 2004) . β-Catenin-mediated canonical Wnt signaling is crucial to muscle development (Borello et al. 1999; Zhang et al. 2012) . One of the key mechanisms by which the β-catenin/ Wnt pathway regulates myogenesis is to induce the expression of basic helix-loop-helix (bHLH) myogenic regulatory factors (MRFs) such as Myf5 and MyoD (Cossu et al. 1996; Tajbakhsh et al. 1998 ) and also inhibitor of differentiation 3 (Zhang et al. 2012) . The β-catenin/Wnt pathway is also essential for the myogenic specification of muscle-derived CD45-positive stem cells after injury (Polesskaya et al. 2003) and for the differentiation of multipotent cells into myogenic cells (Rochat et al. 2004; Pan et al. 2005) . Furthermore, the β-catenin/Wnt pathway is an important regulator of anabolic signaling in skeletal muscle (Armstrong et al. 2006; Armstrong and Esser 2005) .
The paired phosphorylation of β-catenin at its NH 2 terminus by CK1a and glycogen synthase kinase-3β (GSK-3β) plays a crucial role in regulating β-catenin stability and signaling. β-Catenin that is phosphorylated at residues 33 and 37 is recognized by the β-TrCP E3-ligase complex, resulting in its ubiquitylation and rapid degradation by the 26S proteasome (Hart et al. 1999) . This is an important mechanism to turn off Wnt signaling. An accumulated body of evidence suggests that N-terminus phosphorylation directly modulates β-catenin-mediated signaling. Wnt signaling is mediated by N-terminal unphosphorylated β-catenin (Staal et al. 2002) , which readily accumulates in nuclei (Hendriksen et al. 2005; van Noort et al. 2002) . Thus, the GSK-3β-dependent phosphorylation of β-catenin at its Nterminus not only might induce degradation as suggested by the classical view, but might also directly impact β-catenin transcriptional activity. The phosphorylation status alone will therefore regulate β-catenin-mediated Wnt signaling without affecting its stability.
Without Wnt signaling, a sequential phosphorylation of β-catenin by serine/threonine kinases casein kinase Iα (CKIα) at serine 45 and glycogen synthase kinase-3β (GSK-3β) at serine 33/37/threonine 41 results in the ubiquitination and degradation of cytoplasmic β-catenin. Furthermore, the degradation of β-catenin can occur by enhancing its polyubiquitination by Fas-associated factor 1 (Zhang et al. 2011) . The activation of Wnt signaling leads to the inactivation of GSK-3β, resulting in an accumulation of cytoplasmic β-catenin, which translocates to the nucleus and binds to the TCF/LEF transcription factors to induce target gene expression. As a result, the key factors in β-catenin signaling include its stabilization and accumulation in the cytoplasm (Ikeda et al. 1998; Liu et al. 2002) .
Several genes have been identified as having a role in myoblast differentiation. Among these, cadherins appear to play a key role in myogenesis (Liu et al. 2010 ) by inhibiting β-catenin/canonical Wnt signaling (Simcha et al. 2001; Stockinger et al. 2001; Kuphal and Behrens 2006; Sadot et al. 1998) . Reports from several laboratories show that cadherins probably also modulate β-catenin signaling via an adhesion-independent mechanism Simcha et al. 2001; Stockinger et al. 2001) . Recent data indicate that E-cadherin directly promotes β-catenin phosphorylation at the N-terminus by GSK-3β in S2480 colon carcinoma cell lines (Maher et al. 2009 ). β-Catenin phosphorylation has an inhibitory effect on Wnt signaling. This provides a potential mechanism to explain the way that cadherins regulate β-catenin signaling function, at least in cancer cells, although we do not know whether the signaling is similar in muscle cell lines.
M-cadherin is a member of the classical cadherin family of transmembrane glycoproteins, it mediates calciumdependent homophilic cell-cell adhesion, it has been shown to be crucial in regulating myoblast alignment and fusion (Charrasse et al. 2006 (Charrasse et al. , 2007 , and it is required for myogenic differentiation (Wrobel et al. 2007) . We have recently reported that M-cadherin-mediated signaling suppresses GSK-3β activation and protects myoblasts against mitochondrial-associated apoptosis during myogenic differentiation . However, whether M-cadherin plays a role in the regulation of β-catenin phosphorylation at the N-terminus by GSK-3β in myoblasts, and what potential impact this regulation might confer on myogenic differentiation remain unknown.
In the present study, we have investigated the regulatory effect of M-cadherin signaling on β-catenin N-terminal phosphorylation by GSK-3β and the impact of this regulation on myogenic differentiation. We have utilized the C2C12 mouse myoblast line (Silberstein et al. 1986 ), which proliferates in normal culture conditions containing high serum, but which differentiates spontaneously, the cells rapidly fusing to form contractile myotubes, under low serum conditions (Lavulo et al. 2008) . This system provides a controlled model to study the role of M-cadherin during myoblast differentiation. We show that knockdown of Mcadherin expression promotes TCF/LEF transcription activity but decreases the availability of N-terminal unphosphorylated β-catenin (i.e., the active form of β-catenin) in confluent C2C12 myoblasts. This effect can be reversed by treatment with the Wnt pathway activator lithium chloride (LiCl). Furthermore, M-cadherin and β-catenin RNA interference (RNAi) abolishes both myogenic and fibrotic induction by Wnt activation by LiCl. Forced expression of a phosphorylation-resistant mutated β-catenin induces a dramatic increase in TCF/LEF transcription activity but fails to induce myogenic differentiation by itself. However, it partially rescues apoptosis caused by M-cadherin RNAi. Together, these results suggest that M-cadherin signaling suppresses GSK-3β-dependent β-catenin N-terminal phosphorylation and promotes myogenic differentiation.
Materials and methods

Culture conditions
C2C12 myoblasts were purchased from the American Type Culture Collection (ATCC) and maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 10% fetal bovine serum (FBS) and 1% antibiotic and antimycotic mixture (Invitrogen) in a humidified incubator under an atmosphere of 5% CO 2 at 37°C. The myoblasts were cultured in DMEM containing 2% horse serum and 1% antibiotic/antimycotic to induce differentiation. Recombinant Wnt-3a (working concentration: 50 ng/ml) and recombinant Dickkopf-related protein-1 (DKK-1, working concentration: 200 ng/ml) were purchased from R&D Systems (Minneapolis, Minn., USA). LiCl (working concentration: 20 mM) was purchased from Sigma-Aldrich (St. Louis, Mo., USA).
Inhibition of M-cadherin and β-catenin expression by RNAi
SMARTpool small interfering RNA (siRNA) targeted to Mcadherin and β-catenin mRNAs were purchased from Dharmacon/Thermo Scientific (Lafayette, Colo., USA). The Mcadherin-targeted siRNA consisted of duplexes targeting the following sequences: 5′-CGACACAGCUCUCAUCUAU-3′, 5′-GAAGGACGGCUGGUACAGA-3′, 5′-GAGC AAACGCUGAACGUCA-3′, and 5′-UCGACGAGCA CACGGGAGA-3′. The β-catenin-targeted siRNA consisted of duplexes targeting the following sequences: 5′-GAACG CAGCAGCAGUUUGU-3′, 5′-CAGCUGGCCUGGUUU GAUA-3′, 5′-GCAAGUAGCUGAUAUUGAC-3′, and 5′-GAUCUUAGCUUAUGGCAAU-3′. The mouse myoblasts were seeded in six-well plates at a density of 1.7×10
5 per well at 24 h before transfection. siRNA transfection was performed by using either DharmaFECT-3 reagent (when transfected alone) or DharmaFECT-Duo reagent (when cotransfected with plasmids; Thermo Scientific) according to the manufacturer's instructions. The final siRNA duplex concentration in each well was 100 nM.
Plasmids and transfection
The phosphorylation-resistant β-catenin plasmid (pcDNA3-S33Y-β-catenin), the β-catenin/Wnt reporter plasmid super 8× TOPFlash and its mutated control plasmid, and the super 8× FOPFlash were purchased from Addgene (Cambridge, Mass., USA). The plasmids were purified by using an EndoFree plasmid Maxi Kit (Qiagen). The plasmids were transfected into the cells by using either FuGENE 6 reagent (Roche; when transfected alone) or DharmaFECTDuo (Thermo Scientific; when co-transfected with other plasmids or with siRNA) according to the manufacturer's instructions.
Luciferase reporter assay
The cells were transfected with 2 μg super 8×TOPFlash or FOPFlash reporter plasmid and allowed to grow for 24-36 h before further treatment. The myoblasts were harvested in lysis buffer, and luciferase activity was measured in 20 μl samples of each lysate by using a Luciferase Reporter Assay System (Promega, Madison, Wis., USA) according to the manufacturer's instructions. Light units were measured by using a Berthold Autolumat Plus tube luminometer (Berthold Technology, Germany). The luciferase assays were normalized to the corresponding protein concentration of each sample. Each experiment was repeated at least three times. TCF/LEF transcription activity was estimated from the ratio of TOPFlash to FOPFlash luciferase activity from triplicate experiments.
Cell surface biotinylation assay A cell surface biotinylation assay was used to quantify the subcellular (membrane-bound vs. membrane-free) protein abundance of β-catenin at low and high cell densities according to published protocols (Le et al. 1999 ) with minor modifications. Briefly, the cells were washed three times with ice-cold phosphate-buffered saline (PBS)/Ca-Mg solution (138 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 9.6 mM Na 2 HPO 4 , 1 mM MaCl 2 , 0.1 mM CaCl 2 ) and then incubated with EZ link Sulfo-NHS-SS-biotin (1 mg/ml, Pierce) in PBS/Ca-Mg for 30 min at 4°C. The reaction was quenched by two washes with ice-cold 100 mM glycine in PBS/Ca-Mg for 10 min each and three times washes with ice-cold PBS/Ca-Mg. The cells were scraped from the dishes and lysed in ice-cold radioimmunoprecipitation assay buffer (RIPA) buffer containing protease inhibitor cocktail (Sigma, 1:100 dilution). The cell lysates were centrifuged at 15,000 rpm for 30 min at 4°C, and aliquots of supernatants were incubated with streptavidin beads (Sigma, 25 μl beads for 500 μg/500 μl aliquot) for 1 h at 4°C with rotation. The beads were washed three times with ice-cold RIPA buffer. The bound proteins were eluted with 30 μl Laemmli sample buffer (5×) for 5 min at 95-100°C. The whole cell lysates and the unbound fractions were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and processed for immunoblotting ).
Antibodies and immunoblotting
Antibodies specific to phosphorylated β-catenin (serine31/37/ threonine41) and cyclin D1 were purchased from Cell Signaling Technology (Danvers, Mass., USA). The antibody to Mcadherin was from Calbiochem (La Jolla, Calif., USA). The antibody to the serine37/threonine41-unphosphorylated active β-catenin (ABC) was purchased from Millipore (Billerica, Mass., USA). The antibody to total β-catenin was purchased from Sigma. Antibodies to Axin2, Troponin T, and Dglyceraldehyde-3-phosphate dehydrogenase (GAPDH) were obtained from Abcam (Cambridge, Mass., USA). All the secondary antibodies for immunoblotting, including goat antirabbit or goat anti-mouse IgG conjugated with horseradish peroxidase (HRP), were obtained from Jackson ImmunoResearch Laboratories (West Grove, Pa., USA). Immunoblotting of the cell lysates was conducted according to established protocols in our laboratory . Briefly, the cell lysates were diluted in 4× NuPAGE LDS sample buffer (Invitrogen) and heated at 70°C for 10 min. Equal amount of proteins were loaded in a 4%-12% gradient polyacrylamide gel (Invitrogen) and separated by electrophoresis. The proteins were transferred to a nitrocellulose membrane (Bio-Rad), and the membranes were blocked in 5% non-fat milk dissolved in TRIS-buffered saline with 0.05% Tween-20 (TBS-T) for 1 h at room temperature and then probed with primary antibodies overnight at 4°C. This was followed by incubation with secondary antibodies for 1 h at room temperature. The resulting signals were developed by using an Amersham enhanced chemiluminescence lighting (ECL) Western blotting detection reagent kit (GE Health Care) and exposed to films. The protein signals were captured with a digital camera (Kodak 290). The densitometric analysis of the protein bands was obtained via KODAK 1D molecular imaging software.
Cell imaging
The cells were grown on coverslips coated with 1% gelatin. Immunocytochemical staining was conducted on cells that were fixed with fresh 4% paraformaldehyde/PBS, permeabilized with 0.5% Triton X-100/PBS, and blocked with 1% bovine serum albumin (BSA)/PBS. The coverslips were incubated at 4°C overnight in antibodies against mouse anti-β-catenin (Sigma-Aldrich), rabbit anti-β-catenin (Cell Signaling), mouse anti-serine37/threonine41-unphosphorylated ABC (Millipore), mouse anti-myosin heavy chain (MyHC; Developmental Studies Hybridoma Bank), or rat anti-ER-TR7 (Santa Cruz Biotechnology) that were diluted with 1% BSA/PBS. Secondary antibody incubations were carried out at 37°C for 1 h with Alexa Fluor 546 anti-mouse, 488 goat anti-mouse, anti-rabbit, or anti-rat IgG (H+L; Molecular Probes). Nuclei were counter-stained with 4,6-diamidino-2-phenylindole (DAPI), and the cells were mounted in Vectashield mounting medium (Vector). Digital images were obtained with a Zeiss LSM510 confocal laser scanning microscope by using AIM software (Carl Zeiss MicroImaging). The exposure time was 8 s, and the pinhole size for capturing the image was set at 1.
Myogenic differentiation index and fusion index
After 48 h in differentiation media, the cells were stained for MyHC, and the nuclei were stained as described above. MyHC is expressed in differentiated myotubes but not in undifferentiated myoblasts. The number of DAPI-positive nuclei was counted from 10 non-overlapping areas of each coverslip. The differentiation index was determined by identifying myotubes with three or more nuclei and calculating the ratio of the number of nuclei in MyHC-positive cells divided by the total number of nuclei in the same field. The fusion index was calculated as the ratio of the number of nuclei located in myotubes with three or more nuclei, divided by the total number of nuclei in the same field (Hall et al. 2011; Wang et al. 2011 ).
Terminal deoxynucleotidyl transferase dUTP nick end labeling
A terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay (In Situ Cell Death Detection Kit; Roche) was used to identify the extent of apoptotic nuclei in adherent myoblasts as reported previously (Siu et al. 2005; Hao et al. 2011) . The nuclei of all cells were counter-stained with DAPI. The number of TUNEL-and DAPI-positive nuclei was counted in ten images that were chosen randomly from non-overlapping areas of each group. The data were presented as the apoptotic index, which was determined by dividing the total number of TUNEL-positive nuclei by the total number of DAPI-positive nuclei.
Statistical analyses
The results are given as means ± standard error of mean (SE). Statistical analyses were performed by using the SPSS 13.0 software package. A one-way analysis of variance (ANOVA) was used to compare differences in all measured variables. A P-value of<0.05 was considered as being statistically significant.
Results
GSK-3β-dependent phosphorylation of β-catenin at the Nterminus is reduced, and yet TCF/LEF transcription activity is down-regulated in C2C12 myoblasts at high cell density β-Catenin signaling and Wnt activity are regulated by cell confluence in various types of cells (Ishibe et al. 2006; Steel et al. 2005) . The expression level and pattern of cadherin proteins vary as the cell density changes. Cadherin is a central partner that binds to β-catenin and, in turn, regulates both the subcellular distribution and transcription activity of β-catenin.
Thus, in order to examine the phosphorylation status of β-catenin at the N-terminus by GSK-3β, mouse C2C12 mouse myoblasts were seeded at 2.0×10 3 /cm 2 to obtain a low cell density (∼20%-30% confluent) or 2.1×10 4 /cm 2 to reach a high cell density (∼100% confluent) within 48 h.
Immunoblot analyses showed that the protein abundance of phosphorylated β-catenin at residues serine33/37/threonine41 of the N-terminus decreased, and that those of "active" serine37/threonine41-unphosphorylated β-catenin and total β-catenin increased when cells were confluent (Fig. 1a) . In addition, the protein abundance of two target proteins for canonical Wnt signaling, namely Axin2 and cyclin D1, decreased. We next examined the subcellular expression pattern of β-catenin at various cell densities. β-Catenin was located in both the nuclei and the cell cytoplasm, especially in perinuclear regions in cells at a low density (Fig. 1b) . In contrast, β-catenin was detected in the cytoplasm and also more prominently in adjacent cellcell contacting regions when the cells were confluent (Fig. 1b') . The protein abundance of membrane-bound as compared with membrane-free β-catenin was then evaluated via a cell surface biotinylation assay. As shown in Fig. 1c , the ratio of membrane-bound/membrane-free β-catenin was significantly higher in cells that were grown at a high cell density as compared with cells grown at a low density. This finding is . By 48 h after plating, the cells were harvested in lysis buffer for immunoblotting analysis of the protein abundance of phosphorylated (Ser33/37/Thr41) β-catenin, Ser37/Thr41-unphosphorylated active β-catenin (ABC), and total β-catenin. Protein abundance of Axin2 and cyclin D1 were also examined. D-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. b Representative confocal images of β-catenin staining in C2C12 myoblasts at low density (as in a). b' Representative confocal images of β-catenin staining in C2C12 myoblasts at high density (as in a). Objective magnification: 63×. Bar 10 μm. c Representative immunoblots of protein abundance of β-catenin in subcellular fractions (membrane-bound [mem-bound] versus membrane-free [mem-free]) of cells at low or high density as determined by cell surface biotinylation assay. c' Representative immunoblots of protein abundance of β-catenin in total cell lysates. d Comparison of ratios of β-catenin in the membrane-bound fraction with that in the membrane-free fraction in cells at various densities. Each data point (mean ± SEM) is the mean of three independent experiments. *P<0.05 vs. low density group. e C2C12 myoblasts transfected with either a TOPFlash or a FOPFlash plasmid. The cells were then plated at low or high cell density. the cells were harvested 48 h later for luciferase activity measurement to determine the TCF/LEF transcription activity. Each data point (mean ± SEM) is the mean of three independent experiments. *P<0.05 vs. low density group. f, f' Representative images of myosin heavy chain (MyHC)-positive myotubes in cells at low density or high density, respectively, after culture in differentiation medium for 48 h (red MyHC, blue 4,6-diamidino-2-phenylindole [DAPI]). Images were acquired at 20×. Bar 100 μm consistent with the data showing that a large portion of β-catenin translocates to cell-cell adhesive membrane regions in confluent cells (Fig. 1b') .
To examine the difference in canonical Wnt signal activity in cells at various densities, C2C12 cells were transfected with the TOPFlash reporter vector and its mutant control FOPFlash vector, at either low or high cell densities as described above. TCF/LEF transcription activity, as determined from the ratio of luciferase activity in TOPFlash vector-transfected cells normalized to the signals from the FOPFlash vector-transfected cells, was significantly lower in cells that were grown at high density as compared with cells that were grown at a low density (Fig. 1d, e) . However, in spite of the decreased TCF/ LEF transcription activity, myogenic differentiation, as shown by immunofluorescent staining of MyHC-positive myotubes in differentiation medium for 48 h, was comparatively lower in cells grown at a low density (Fig. 1f) but was clearly enhanced in confluent C2C12 myoblasts (Fig. 1f' ). These data suggest that the phosphorylation of β-catenin at its Nterminus by GSK-3β is suppressed, and that TCF/LEF transcription is also down-regulated when C2C12 myoblasts become confluent. Our results show that myogenic potential is much higher in confluent myoblasts compared with cells with a low density, but that the TCF/LEF transcription activities change in the opposite way. Thus, the high myogenic outcome of confluent myoblasts is independent of TCF/LEF transcription activity.
M-cadherin RNAi increases phosphorylation of β-catenin N-terminus at Ser31/37/Thr41 but enhances TCF/LEF transcription activity
We have reported previously that M-cadherin-mediated signaling suppresses GSK-β activation in confluent myoblasts . To investigate further whether Mcadherin-mediated signaling modulates GSK-3β-dependent N-terminal phosphorylation of β-catenin and the impact of this potential modulation on TCF/LEF transcription activity in confluent C2C12 myoblasts, we inhibited M-cadherin expression in confluent C2C12 myoblasts via M-cadherin RNAi and subsequently treated the cells with LiCl, an established GSK-3β inhibitor and Wnt activator. LiCl inhibits GSK-3β activity by competition with ATP in the ATPbinding site of the kinase via directly competing with magnesium and by increasing the inhibitory phosphorylation of the Serine 9 residue of GSK-3β (Klein and Melton 1996) . The knockdown efficacy of M-cadherin expression was verified by immunoblotting (Fig. 2a) . The protein abundances of phospho-and total β-catenin and of the unphosphorylated ABC were analyzed by immunoblotting. The protein abundances of both total β-catenin and unphosphorylated ABC were significantly increased when GSK-3β activity was inhibited by LiCl (Fig. 2b) , whereas knockdown of Mcadherin by RNAi prevented this effect (Fig. 2c', c'' ). In addition, M-cadherin RNAi alone significantly increased the phosphorylation of β-catenin at its N-terminus, and the inhibition of GSK-3β activity effectively reversed this induction (Fig. 2c) . Compared with the control cells that were transfected with scrambled siRNA, knocking down Mcadherin by RNAi did not alter the protein abundance of total β-catenin (Fig. 2c'' ), but it decreased the abundance of unphosphorylated ABC. This effect could be rescued by inhibiting GSK-3β activity via LiCl treatment (Fig. 2c') . These results suggest that M-cadherin-mediated signaling attenuates the phosphorylation of β-catenin at its Nterminus and maintains unphosphorylated ABC in a GSK-3β-dependent manner.
We further investigated the subcellular expression pattern of the unphosphorylated ABC in confluent myoblasts and the effect of M-cadherin RNAi and/or inhibition of GSK-3β activity on β-catenin. β-catenin was localized primarily to cell-cell contact regions and in the cell cytoplasm without inhibition of GSK-3β activity (Fig. 3a, b ). Staining patterns with the anti-ABC antibody demonstrated that unphosphorylated ABC mainly resided in the cytoplasmic space (Fig. 3a' , a''', b', b''') and not at cell-cell contacting membrane regions. In addition, inhibition of GSK-3β activity via LiCl treatment translocated unphosphorylated ABC into the cell nuclei (Fig. 3a', b' ). These results suggest that the unphosphorylated active form of β-catenin is most responsive to the inhibition of GSK-3β-activity-induced Wnt activation. However, M-cadherin RNAi did not alter the expression pattern of ABC (Fig. 3c', c'' ', d', d'''), and total β-catenin (Fig. 3c, c''', d, d '''), with or without inhibition of GSK-3β activity via LiCl treatment.
We then examined the change in TCF/LEF transcription activity in response to the knockdown of M-cadherin mRNA by using reporter (luciferase) assays. As shown in Fig. 4a , in spite of the statistically significant decrease in the protein abundance of ABC, TCF/LEF transcription activity was increased in cells transfected with M-cadherin-targeted siRNA compared with that in the control groups. To verify further the role of M-cadherin in regulating TCF/LEF transcription activity, we co-transfected the cells with Mcadherin-targeted siRNA and TOPFlash/FOPFlash-reporter plasmids and then treated the cells with either LiCl or recombinant Wnt-3a for 12 h (Fig. 4b) . The luciferase activity was measured in cells at the end of treatments. The reporter (luciferase) assays (Fig. 4a, b) were normalized to the corresponding protein concentration of each sample. Each experiment was repeated at least three times. Both the inhibition of GSK-3β activity by LiCl and the treatment of the cells with Wnt-3a induced a significant increase in TCF/ LEF transcription activity, and both inductions were significantly enhanced in cells transfected with M-cadherin-targeted siRNA (Fig. 4b) .
Reducing M-cadherin expression blunts myogenic and fibrotic induction by inhibition of GSK-3β activity To examine further the effect of knocking down M-cadherin gene expression on the phenotype of myoblasts induced by the inhibition of GSK-3β activity or an increase in Wnt activity, C2C12 myoblasts were transfected with either an M-cadherin-targeted or a scrambled non-targeted siRNA and then treated with LiCl (an inhibitor of GSK-3β activity) or recombinant Wnt-3a for 12 h. The cells were treated for 48 h to induce myotubes and then harvested for immunoblotting analysis. The protein abundance of Troponin T, an established marker for terminal myogenic differentiation (Breitbart and Nadal-Ginard 1987; Yao et al. 1992) , was significantly increased in cells after the inhibition of GSK-3β activity by LiCl to increase Wnt signaling or by Wnt3a treatment compared with vehicle-treated control cells (Fig. 5a, b) . However, M-cadherin RNAi significantly attenuated the induction of Troponin T expression in both vehicle and LiCl/Wnt-3a-treated cells. Further morphological examination via immunofluorescent staining of MyHC-positive myotubes and nuclei (Fig. 6a) showed that the inhibition of GSK-3β activity by LiCl treatment (which increases Wnt signaling) induced a significant increase in both myogenic differentiation (Fig. 6b) and fusion (Fig. 6b') as determined from the differentiation and fusion indices. The myogenic differentiation and the fusion inductions were both significantly blunted by M-cadherin RNAi (Fig. 6b, b' ).
Since dysregulated increases in Wnt signaling could potentially skew the myogenic progenitor cells into fibrotic lineages (Brack et al. 2007 (Brack et al. , 2008 , we examined the expression of a fibroblast marker, ER-TR7 (Brack et al. 2007; Van Vliet et al. 1986 ) in cells after the various treatments ( Fig. 7a-a'' ). Inhibition of GSK-3β activity by LiCl induced a substantial increase in the expression of ER-TR7 in C2C12 myoblasts (Fig. 7a') , whereas M-cadherin RNAi effectively abrogated this induction (Fig. 7a'' . These results suggest that M-cadherin plays a positive role in mediating myogenic and fibrotic induction by Wnt signal activation caused by the inhibition of GSK-3β activity by LiCl.
Inhibiting β-catenin expression and canonical Wnt signaling reverses myogenic and fibrotic induction by inhibiting GSK-3β activity To confirm the role of β-catenin/Wnt signaling in mediating the myoblast phenotype induced by the inhibition of GSK-3β activity, we treated the cells either with β-catenin RNAi to inhibit β-catenin expression or with DKK-1, an established antagonist of canonical Wnt signaling. This was followed by treatment of the cells with LiCl for 12 h to inhibit GSK-3β activity and with differentiation medium for 48 h to induce myogenic differentiation. The efficacy of β-catenin knockdown by RNAi was verified by immunoblotting of β-catenin protein abundance (Fig. 8a) . The cell morphology of the differentiated cells was examined by immunofluorescent staining of MyHC-positive myotubes and nuclei (Fig. 8b-b'' ). The differentiation (Fig. 8c) and fusion (Fig. 8c') indices were determined and compared among cells after the appropriate treatments. Whereas myotube formation increased with the LiCl-induced inhibition of GSK-3β activity, this was largely prevented in β-catenin-RNAi-treated cells as seen by a significant reduction in both the differentiation and fusion of myoblasts as compared with cells treated with LiCl (Fig. 8c,  c' ). Both DKK-1 (Fig. 8b'', c' ) and β-catenin RNAi (Fig. 8b,  c' ) attenuated the increased myogenic induction by LiCl treatment; however, β-catenin RNAi had the greatest effect (Fig. 8b', c') . Similarly, both β-catenin RNAi and DKK-1 treatment significantly blocked the expression of the fibrotic marker, ER-TR7, which was induced by LiCl treatment (Fig. 9a-a'' ), but a greater effect was seen by inhibiting β-catenin expression (Fig. 9b) . These results show that the myogenic and fibrotic induction by inhibition of GSK-3β activity is mediated by β-catenin/Wnt signaling.
Forced expression of phosphorylation-resistant β-catenin partially rescues the blunting effect of reducing M-cadherin expression on the myogenic phenotype induced by inhibition of GSK-3β activity To clarify further the importance of phosphorylation of the Nterminus of β-catenin in regulating myogenesis, we transfected a phosphorylation-resistant mutated β-catenin (S33Y-β-catenin) plasmid into C2C12 myoblasts and induced myogenic differentiation. The expression efficacy of the β-catenin plasmid was verified by immunoblotting the protein abundance of phospho-, unphosphorylated, and total β-catenin (Fig. 10a) . Forced expression of S33Y-β-catenin in C2C12 myoblasts induced a significant increase in TCF/LEF transcription activity (Fig. 10b ) but failed to increase the protein abundance of Troponin T as determined by immunoblotting after transfection with the S33Y-β-catenin plasmid (Fig. 10c) , β-catenin, or M-Cadherin (data not shown). This observation indicated that the expression of the phosphorylation-resistant mutant form of β-catenin increased TCF/LEF transcription activity and yet had no effect on the myogenic differentiation of C2C12 cells. TCF/LEF activity was also increased over control levels after the inhibition of M-cadherin RNA and was further increased when M-cadherin knockdown was combined with the S33Y-β-catenin plasmid. In contrast, LiClinduced inhibition of GSK-3β activity in cells that were cotransfected with both S33Y-β-catenin and M-cadherin siRNA yielded an increased protein abundance of Troponin T compared with cells that were transfected with M-cadherin siRNA (Fig. 10d, d' ). This suggests that the phosphorylationresistant form of β-catenin attenuates the blunting effect of Mcadherin RNAi on myogenic induction by LiCl treatment.
Forced expression of phosphorylation-resistant (mutated) β-catenin partially attenuates apoptosis exacerbated by M-cadherin RNAi during myogenic differentiation
We have shown previously that M-cadherin RNAi exacerbates apoptosis in myoblasts during myogenic differentiation . We examined this further in an attempt to determine whether the phosphorylation status of β-catenin Nterminus played a role in regulating the apoptotic phenotype caused by M-cadherin RNAi. M-cadherin-targeted siRNA and S33Y-β-catenin plasmids were either transfected alone or co-transfected into C2C12 myoblasts followed by culture of the cells in differentiation medium for 48 h to induce myotube formation. At the end of the treatments, the cells were fixed and stained with an anti-MyHC antibody to evaluate the differentiated myotubes. In situ apoptotic DNA LiCl-treated group fragmentation was examined after the cells were stained with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and the nuclei were counter-stained with DAPI ( Fig. 11a-b''' ). The indices for differentiation and apoptosis were calculated and compared among cells following various treatments. Forced expression of S33Y-β-catenin alone did not alter the myogenic (Fig. 11c) or the apoptotic (Fig. 11d) outcomes in C2C12 cells at the end of 48 h of myogenic differentiation. However, co-transfection of S33Y-β-catenin with M-cadherin siRNA partially rescued the impaired myogenic differentiation (Fig. 11b''', c) and attenuated the exacerbated apoptosis caused by M-cadherin RNAi alone (Fig. 11d) . These results suggest that the alteration of the phosphorylation status of β-catenin at its N-terminus mediates the apoptotic phenotype induced by the disruption of Mcadherin-mediated signaling.
Discussion β-Catenin/Wnt signaling is important for the initiation and progression of skeletal muscle development and regeneration.
Furthermore, β-catenin is required to maintain muscle cell proliferation and acts as a molecular switch to regulate myogenic differentiation (Tanaka et al. 2011) . This is the first study to show that M-cadherinmediated signaling regulates β-catenin N-terminal phosphorylation at Ser31/37/Thr41 and, therefore, β-catenin/ Wnt signaling, and that this promotes myogenic differentiation in a TCF/LEF-transcription-independent manner. In this study, we have observed that reduced M-cadherin gene expression increases the GSK-3β-dependent phosphorylation of β-catenin at the N-terminus Ser31/37/ Thr41, decreases the protein abundance of unphosphorylated signaling-ABC, and blunts the myogenic induction caused by elevated Wnt signaling via the inhibition of GSK-3β activity or Wnt-3a treatment. Forced expression of phosphorylation-resistant β-catenin (to increase ABC) fails to enhance myogenic differentiation but partially rescues the myogenic and apoptotic phenotype influenced by M-cadherin RNAi. Interestingly, these effects are independent of changes in TCF/LEF transcription activity. The results from the experiments in this study are summarized in Table 1 . Fig. 8 Effect of reducing β-catenin gene expression and inhibiting canonical Wnt signaling on myogenic induction via inhibition of GSK-3β activity. a Representative immunoblot of protein abundance of β-catenin in C2C12 myoblasts after no treatment (NC), after transfection with a non-targeted scrambled siRNA (SiCON), or after knocking down β-catenin gene expression via transfection with RNAi (β-catenin-targeted siRNA transfection). GAPDH was used as a loading control. b-b'' Representative confocal images of MyHC-positive C2C12 myotubes to show differentiation in C2C12 cells after transfection with a non-targeted scrambled siRNA (SiCON; b), after knocking down β-catenin gene expression via transfection with RNAi (β-catenin-targeted siRNA transfection; b'), or after treatment with Dickkopf-related protein-1 (DKK-1, 200 ng/ml; b") to inhibit canonical Wnt signaling. All treatments were followed by the addition of LiCl to inhibit GSK-3β activity. The treatment conditions were for 12 h, followed by incubation in differentiation medium for 48 h (red MyHC, blue DAPI). Images were acquired at 20×. Bar 100 μm. c, c' The differentiation index and the apoptotic index, respectively, were quantified for the C2C12 cells after the treatments described (a-b"). *P<0.05 vs.
LiCl plus SiCON group
Cadherin regulation of β-catenin transcription Cadherin proteins clearly modulate β-catenin transcription activity in a variety of cells including Chinese hamster ovary and SW480 colon carcinoma cell lines (Sadot et al. 1998) . In addition, the transient expression of exogenous E-cadherin has been reported to arrest cell growth via the inhibition of β-catenin transcriptional activity in epithelial and fibroblastoid cells (Stockinger et al. 2001) . Cadherins also play an important role in myogenesis (Liu et al. 2010 ) by inhibiting β-catenin/canonical Wnt signaling (Kuphal and Behrens 2006) .
Translocation of β-catenin in myogenesis
The translocation of β-catenin appears to play an important role in determining its activity in various cell lines (Kuphal and Behrens 2006; . We have demonstrated in this study that unphosphorylated ABC accumulates in cytoplasmic regions and not at cell-cell contacts in confluent myoblasts. In response to the inhibition of GSK-3β activity to enhance Wnt activity (by LiCl treatment), ABC but not total β-catenin translocates into the nuclei, indicating that ABC is responsive to Wnt stimulation. Similar to our observation in myoblasts, several other groups have demonstrated that β-catenin translocates to cell-cell junctions, and that this increase occurs during the initiation of myogenic differentiation (Goichberg et al. 2001) . As RhoA activity is required for β-catenin recruitment to intercellular adhesions sites (Charrasse et al. 2002) , it is noteworthy that N-cadherin-dependent cell-cell contact activates muscle-specific promoters and RhoA in C2C12 cells. Our results suggest that M-cadherin-mediated signaling helps in maintaining a cytosolic pool of unphosphorylated signaling-ABC, which plays a critical role in myogenic induction by Wnt stimulation.
M-cadherin regulates the phosphorylation status on the N-terminus Ser31/37/Thr41 of β-catenin β-Catenin is important in myoblast differentiation as it downregulates myostatin and induces hypertrophy (Bernardi et al. 2011) , and the loss of β-catenin prevents muscle fiber hypertrophy (Armstrong et al. 2006 ). In the current study, we show, for the first time, that the inhibition of M-cadherin expression by RNAi increases the phosphorylation of β-catenin on Fig. 9 Effect of reducing β-catenin gene expression and inhibiting canonical Wnt signaling on fibrotic induction via inhibition of GSK-3β activity. a-a'' Representative confocal images of immunofluorescent staining of the fibrotic marker, ER-TR7, in C2C12 myoblasts after transfection with a non-targeted scrambled siRNA (SiCON; a), after knocking down β-catenin gene (β-CAT) expression via transfection with RNAi (β-CAT RNAi, β-catenin-targeted siRNA transfection; a'), or after treatment with DKK-1 (200 ng/ml) to inhibit canonical Wnt signaling (a''). All treatments were followed by the addition of LiCl to inhibit GSK-3β activity (green ER-TR7, blue DAPI). Images were acquired at 20×. Bar 100 μm. b Quantitative analysis of mean fluorescence intensity of ER-TR7 staining in cells with the treatments described in Fig. 8 . *P<0.05 vs. LiCl plus SiCON group the N-terminus at Ser31/37/Thr41, decreases the protein abundance of unphosphorylated ABC, and impairs the myogenic induction that is caused by either the inhibition of GSK-3β activity or Wnt-3a treatment. Together, these results indicate that M-cadherin-mediated signaling attenuates GSK-3β-dependent phosphorylation of the β-catenin N-terminus at Ser31/37/Thr41 and helps in maintaining a cytosolic pool of unphosphorylated signaling-ABC, which plays a critical role in myogenic induction by Wnt stimulation. In our study, we treated the cells with Wnt3a, but we did not test whether other Wnt family members would provide different results. This is a possibility, because Wnt3a overexpression has been reported to decrease C2C12 differentiation, but Wnt 4 does not alter C2C12 differentiation (Tanaka et al. 2011) . However, an evaluation of M-Cadherin on the various Wnt signaling proteins was beyond the scope of this study.
M-cadherin-mediated signaling attenuates phosphorylation of β-catenin N-terminus at Ser31/37/Thr41 via suppressing GSK-3β activity
We have shown previously that M-cadherin suppresses GSK-3β activity in confluent myoblasts . In the present study, we further demonstrate that, whereas a large portion of β-catenin is detected at cell-cell contact membrane regions, in confluent myoblasts, unphosphorylated ABC is located mainly in cytoplasmic regions of the cell rather than at cell-cell contacts. This observation suggests that the phosphorylation regulatory effect by M-cadherin is not simply a Table 1 Summary of major biological outcomes of this study (ABC active β-catenin, siRNA small interfering RNA, GSK-3β glycogen synthase kinase-3β, S33Y-β-catenin phosphorylation-resistant mutated β-catenin plasmid, TCF/LEF T cell factor/lymphoid enhancer factor, ↑ increase, ↓ decrease, → no change)
Treatment
Desired outcome Biological outcome
significantly reverses this effect. These results indicate that Mcadherin-mediated signaling attenuates the phosphorylation of the β-catenin N-terminus at Ser31/37/Thr41 through the suppression of GSK-3β activity. The exact mechanism by which M-cadherin-mediated signaling attenuates the phosphorylation of the β-catenin N-terminus at Ser31/37/Thr41 remains to be elucidated.
TCF/LEF transcription activity is less dependent on the phosphorylation status of β-catenin N-terminus at Ser31/37/Thr41 than on the mechanical sequestration of β-catenin by M-cadherin
Our results show that the myogenic potential is much higher in confluent myoblasts as compared with cells with a low density, but that TCF/LEF transcription activities change in the opposite way (Fig. 1a-f' ). Although knockdown of M-cadherin by RNAi promotes TCF/LEF transcription activity under both steady state and LiCl/Wnt-3a-treatment conditions (Figs. 1e, 10b), it blunts myogenic differentiation under these conditions.
Although the inhibition of the gene expression of M-cadherin and the forced expression of the phosphorylation-resistant form of β-catenin induces a substantial increase in TCF/LEF transcription activity, this treatment fails to induce a similar increase in myogenic differentiation by itself. These results show that a disconnection exists between the level of TCF/LEF transcription activity and the outcome of myogenic differentiation in myoblasts. This observation further suggests that β-catenin mediates Wnt signaling and promotes myogenic differentiation independently of its role in enhancing TCF/LEF transcription activity. These findings are however consistent with reports from treated LIM2537 cells (a poorly-differentiated colon cancer cell line), which, when treated with the potent differentiating agent sodium butyrate, reduce their GSK-3β activity by 34% and stabilize their levels of cytoplasmic β-catenin but exhibit no increase in the β-catenin/TCF target genes c-myc and cyclin D1 (Vincan et al. 2000) . Previous work has shown that β-catenin interacts with I-mfa (an inhibitor of the MyoD family of muscle Fig. 12 Representation of the regulatory role of M-cadherin on β-catenin phosphorylation in myogenic differentiation. Cadherin is an established inhibitor of β-catenin/canonical Wnt signaling. In myoblasts, it inhibits β-catenin activity by mechanical sequestration, at the muscle cell membrane, but it also attenuates the phosphorylation of the β-catenin N-terminus at Ser31/37/ Thr41 to increase the active ABC form of β-catenin, and promotes β-catenin activity in a TCF/ LEF-independent manner (GSK-β glycogen synthase kinase-β, MRFs myogenic regulatory factors, TCF/LEF T cell factor/lymphoid enhancer factor) regulatory transcription factors, the MRFs), and that this interaction relieves the transcription activity suppression and cytosolic sequestration of MRFs by I-mfa (Pan et al. 2005) . This observation suggests that a β-catenin-dependent, but TCF/LEF-independent, regulatory mechanism impacts MRFs during myogenesis. Similarly, Kim and colleagues (2008) report that TCF/LEF activity is dispensable for the role of β-catenin in promoting myogenic differentiation. Instead, β-catenin directly interacts with MyoD and enhances its transcriptional activity, which is necessary for myogenic differentiation (Kim et al. 2008) . Interestingly, the results in our present study show that TCF/LEF transcription activity is increased in response to M-cadherin RNAi, in spite of the decreased availability of unphosphorylated ABC, suggesting that TCF/LEF transcription activity might be more responsive to the relief of the mechanical sequestration of β-catenin by M-cadherin knockdown and less dependent on the change in the phosphorylation status of the β-catenin N-terminus at Ser31/37/Thr41, at least in C2C12 myoblasts.
Fibrotic induction caused by Wnt stimulation is reversed by M-cadherin and β-catenin
Although skeletal muscle progenitor cells are committed to myogenic lineages and do not spontaneously adopt nonmyogenic fates (Starkey et al. 2011) , hyper-activation of Wnt signaling can induce the premature termination of the expansion of myogenic progenitor cells and push the myogenic progenitor cells toward fibroblast lineages, resulting in increased fibrosis in muscle tissues (Brack et al. 2007 (Brack et al. , 2008 . Consistent with this finding, we have demonstrated that the inhibition of GSK-3β activity to enhance Wnt signaling in C2C12 myoblasts prior to differentiation gives rise to the expression of a fibroblast marker, ER-TR7. The fibrotic induction caused by Wnt stimulation via the inhibition of GSK-3β activity (i.e., LiCl treatment) can be effectively reversed by the inhibition of the expression of either M-cadherin or β-catenin expression.
Phosphorylation of β-catenin at the N-terminus Ser31/37/Thr41 position mediates apoptosis that occurs from reduced M-cadherin expression during myogenic differentiation
We have shown previously that the knockdown of Mcadherin expression via RNAi in both C2C12 myoblasts and primary muscle progenitor cells exacerbates apoptosis during myogenic differentiation. This increase in apoptotic signaling is partially rescued by the inhibition of GSK-3β activity ). In the current study, we extend these observations by showing that M-cadherin RNAi increases the phosphorylation of the β-catenin Nterminus at Ser31/37/Thr41, and that forced expression of the phosphorylation-resistant mutated β-catenin partially rescues the apoptosis induced by M-cadherin RNAi. These observations suggest that an alteration in the phosphorylation levels of the β-catenin N-terminus at Ser31/37/Thr41 and β-catenin/Wnt signaling is at least partially responsible for mediating M-cadherin RNAi-induced apoptosis during myogenic differentiation. Our findings here are consistent with reports that show that β-catenin/Wnt signaling plays an important role in promoting the survival of either skeletal or cardiac myoblasts under various conditions (Almeida et al. 2005; Du et al. 2009; Hahn et al. 2006; Li et al. 2011 ).
Concluding remarks
β-Catenin is a key player in signal transduction pathways during muscle development. Novel data in this study show that M-cadherin-mediated signaling attenuates β-catenin phosphorylation at Ser31/37/Thr41 by GSK-3β, and that this regulation has a positive effect on myogenic differentiation induced by canonical Wnt signaling. Unphosphorylated β-catenin is the active form of this protein, and M-cadherin reduces the degree to which β-catenin becomes phosphorylated at the N-terminus Ser31/37/Thr41 position. Thus, M-cadherin helps to maintain a high cytosolic pool of the N-terminal unphosphorylated (at Ser31/37/Thr41) signaling-ABC, which in turn, plays a key role in mediating canonical Wnt signaling to promote myogenic differentiation in a TCF/LEF-independent manner (Fig. 12) . M-cadherin-mediated reduction in the phosphorylation of β-catenin together with various Wnt ligands (Tanaka et al. 2011) might provide important mechanisms that regulate the translocation of β-catenin to control the differentiation of muscle cells.
